BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 27
• 28
• 29
• 30

• Drug Development

  Sunovion Pharmaceuticals Inc. Release: New STEDESA(TM) Clinical Data Presented at American Epilepsy Society Annual Meeting

  December 6, 2010

   · 

  1 min read
• Drug Development

  Biocryst Pharmaceuticals Reports New Data from Its Phase 2 Forodesine Study in Patients with Chronic Lymphocytic Leukemia at the 52nd Annual American Society of Hematology Meeting

  December 6, 2010

   · 

  1 min read
• Drug Development

  Ligand Pharmaceuticals Inc. Announces Positive Preclinical Data on Small Molecule Erythropoietin Receptor Agonists

  December 6, 2010

   · 

  1 min read
• Pharm Country

  EpiCept Corporation Announces Ceplene(R) Poster Presentation at the 52nd Annual Meeting of the American Society of Hematology

  December 6, 2010

   · 

  1 min read
• Business

  Asuragen, Inc. Announces Collaboration on the Development of BCR-ABL1 RNA IS Calibrators and Laboratory Software Reporting Tool at American Society of Hematology

  December 6, 2010

   · 

  1 min read
• Drug Development

  Immunomedics, Inc.'s Results From Phase II Trial of Epratuzumab and Rituximab as Initial Treatment for Follicular Lymphoma Reported in an Oral Presentation at American Society of Hematology

  December 6, 2010

   · 

  1 min read
• Drug Development

  Incyte Corporation Presents Positive Long-Term Results from Ongoing Phase II Trial of INCB18424 in Advanced Polycythemia Vera (PV) and Essential Thrombocythemia (ET) at the American Society of Hematology Annual Meeting

  December 6, 2010

   · 

  1 min read
• China Nuokang Bio-Pharmaceutical Inc. to Participate in 29th Annual J.P. Morgan Healthcare Conference

  December 6, 2010

   · 

  1 min read
• BioMidwest

  Allos Therapeutics, Inc. Reports New Analyses of FOLOTYN(R) Data from PROPEL Trial in Relapsed or Refractory Peripheral T-Cell Lymphoma

  December 6, 2010

   · 

  1 min read
• Drug Development

  ImmunoGen, Inc. Announces Presentation of Positive Initial Clinical Data for IMGN901 Used in a Combination Regimen for Multiple Myeloma

  December 6, 2010

   · 

  1 min read